ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 15 filers reported holding ZEALAND PHARMA A S in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | -12.5% | 509 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -33.3% | 509 | -7.3% | 0.00% | – |
| Q4 2021 | $12,000 | -29.4% | 549 | -2.1% | 0.00% | – |
| Q3 2021 | $17,000 | 0.0% | 561 | -1.8% | 0.00% | – |
| Q2 2021 | $17,000 | +142.9% | 571 | +158.4% | 0.00% | – |
| Q1 2021 | $7,000 | 0.0% | 221 | +3.3% | 0.00% | – |
| Q4 2020 | $7,000 | -30.0% | 214 | -17.7% | 0.00% | – |
| Q3 2020 | $10,000 | +11.1% | 260 | 0.0% | 0.00% | – |
| Q2 2020 | $9,000 | +12.5% | 260 | +9.7% | 0.00% | – |
| Q1 2020 | $8,000 | – | 237 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 510,000 | $18,329,000 | 0.11% |
| AWM Investment Company, Inc. | 19,981 | $718,000 | 0.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 5,653 | $203,000 | 0.06% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,099,546 | $39,517,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 10,000 | $359,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 235 | $8,000 | 0.00% |
| Renaissance Technologies | 17,205 | $618,000 | 0.00% |
| JANE STREET GROUP, LLC | 35,707 | $1,283,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Parallel Advisors, LLC | 94 | $3,000 | 0.00% |